Deep brain stimulation (DBS) stabilizes motor function in patients with Parkinson’s disease (PD), long-term data suggest.
The VA/NINDS randomized trial known as CSP468F was a landmark multicenter study comparing the effects of two targets for DBS – the subthalamic nucleus (STN) and globus pallidus interna (GPi) – in patients with PD.